Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Trading Update & Acquisitions

29 Jun 2010 07:00

RNS Number : 3866O
CVS Group plc
29 June 2010
 



 

Trading update and Acquisitions

 

The Board announced on 19 May 2010 that it expected results for the year to be below market expectations. Trading conditions have remained tough throughout the rest of the group's financial year which will end on 30 June 2010. Having reviewed flash numbers the Board now believes that turnover for the year will be in the region of £85m (net of inter company sales of £2m). This is in the region of £1m below Directors' expectations for the final quarter.

 

Whilst the Board is disappointed to report lower than anticipated turnover, the performance will still reflect modest like-for-like growth for the year as a whole (after adjusting for the weather affected months of December 2009 and January 2010) despite the challenging environment.

 

The Board is pleased to report that the Group has delivered a better than expected level of acquisition activity in the year, which is expected to generate annualised turnover in the region of £21 million, compared to the £12m expected at the start of the financial year. However, as previously highlighted, the bulk of these have been acquired in the latter part of the financial year, which means that they will only deliver £6 million of sales in this current year. The total number of surgeries acquired in the year amounted to 41 together with one laboratory.

 

Three new acquisitions have been completed in June funded by internally generated cash, comprising five surgeries located in the vicinity of Mansfield, Horsham and Burgess Hill respectively. The combined annual turnover for the five surgeries is circa £2.7 million.

 

Senior Management Appointment

The Board is also pleased to confirm the recent appointment of Steve Scully as the Director of Practice Operations for the Group. Steve will sit on the Executive Committee and brings with him a broad range of experience and a proven track record in driving growth within large multi site operations.

 

 

For further enquiries please contact:

CVS Group plc

Simon Innes, Chief Executive

Paul Coxon, Finance Director

01379 644 288

 

 

Brewin Dolphin

Richard Jones/Matt Davis

Paul Mason

0845 059 6740

 

 

Buchanan Communications

Richard Oldworth

Ben Romney

020 7466 5000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTKKFDPKBKBNAB

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.